When to Use Antibiotics in COVID-19: A Proposal Based on Questions
The COVID-19 pandemic has affected millions of people, including hundreds of deaths. The search for adequate treatments and interventions that influence poor prognostic factors and reduce mortality has led to excessive use of antibiotics based on the possible existence of bacterial co-infection. How...
Gespeichert in:
| Veröffentlicht in: | Curēus (Palo Alto, CA) CA), 2022-07, Vol.14 (7), p.e27398 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 7 |
| container_start_page | e27398 |
| container_title | Curēus (Palo Alto, CA) |
| container_volume | 14 |
| creator | Dueñas-Castell, Carmelo Polanco-Guerra, Camilo Jose Martinez-Ávila, Maria Cristina Almanza Hurtado, Amilkar J Rodriguez Yanez, Tómas Gutierrez-Ariza, Juan Camilo Rico-Fontalvo, Jorge |
| description | The COVID-19 pandemic has affected millions of people, including hundreds of deaths. The search for adequate treatments and interventions that influence poor prognostic factors and reduce mortality has led to excessive use of antibiotics based on the possible existence of bacterial co-infection. However, there is no evidence to justify the systematic use of antimicrobials in COVID-19. The recommendations seek to provide knowledge regarding treatment; standardizing a management algorithm requires validation in clinical trials and studies of greater methodological rigor. |
| doi_str_mv | 10.7759/cureus.27398 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9418620</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2709018014</sourcerecordid><originalsourceid>FETCH-LOGICAL-c342t-7f22d591bc13dcfc055b2ac5f16927b4be98de4ffec7b7d624e22611b62222663</originalsourceid><addsrcrecordid>eNpdkc1LAzEQxYMoVmpvniXgxYNbk2w22XgQ2voJhSpYPYZsNquRbVKTXcH_3q2tos5lBubH4z0eAAcYDTnPxKlug2njkPBU5Ftgj2CWJznO6favuwcGMb4ihDDiBHG0C3opQ5QRwffA-OnFONh4OI8GjlxjC-sbqyO0Dk5mj7cXCRZncATvgl_6qGo4VtGU0Dt435rYWO_iPtipVB3NYLP7YH51-TC5Saaz69vJaJrolJIm4RUhZSZwoXFa6kqjLCuI0lmFmSC8oIUReWloVRnNC14yQg0hDOOCkW4YS_vgfK27bIuFKbVxTVC1XAa7UOFDemXl34-zL_LZv0tBcc4I6gSONwLBv63cy4WN2tS1csa3URKOBMI5wrRDj_6hr74Nrou3onLGhKArwZM1pYOPMZjqxwxGctWPXPcjv_rp8MPfAX7g7zbST9thirU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2708669940</pqid></control><display><type>article</type><title>When to Use Antibiotics in COVID-19: A Proposal Based on Questions</title><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Dueñas-Castell, Carmelo ; Polanco-Guerra, Camilo Jose ; Martinez-Ávila, Maria Cristina ; Almanza Hurtado, Amilkar J ; Rodriguez Yanez, Tómas ; Gutierrez-Ariza, Juan Camilo ; Rico-Fontalvo, Jorge</creator><creatorcontrib>Dueñas-Castell, Carmelo ; Polanco-Guerra, Camilo Jose ; Martinez-Ávila, Maria Cristina ; Almanza Hurtado, Amilkar J ; Rodriguez Yanez, Tómas ; Gutierrez-Ariza, Juan Camilo ; Rico-Fontalvo, Jorge</creatorcontrib><description>The COVID-19 pandemic has affected millions of people, including hundreds of deaths. The search for adequate treatments and interventions that influence poor prognostic factors and reduce mortality has led to excessive use of antibiotics based on the possible existence of bacterial co-infection. However, there is no evidence to justify the systematic use of antimicrobials in COVID-19. The recommendations seek to provide knowledge regarding treatment; standardizing a management algorithm requires validation in clinical trials and studies of greater methodological rigor.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.27398</identifier><identifier>PMID: 36046297</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Antibiotics ; Antimicrobial agents ; Bacterial infections ; Coronaviruses ; COVID-19 ; Cytokines ; Drug resistance ; Infectious Disease ; Mortality ; Pandemics ; Patients ; Pneumonia ; Public Health ; Pulmonology ; Severe acute respiratory syndrome coronavirus 2 ; Staphylococcus infections ; Viral infections ; Viruses</subject><ispartof>Curēus (Palo Alto, CA), 2022-07, Vol.14 (7), p.e27398</ispartof><rights>Copyright © 2022, Dueñas-Castell et al.</rights><rights>Copyright © 2022, Dueñas-Castell et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2022, Dueñas-Castell et al. 2022 Dueñas-Castell et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c342t-7f22d591bc13dcfc055b2ac5f16927b4be98de4ffec7b7d624e22611b62222663</citedby><cites>FETCH-LOGICAL-c342t-7f22d591bc13dcfc055b2ac5f16927b4be98de4ffec7b7d624e22611b62222663</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418620/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418620/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36046297$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dueñas-Castell, Carmelo</creatorcontrib><creatorcontrib>Polanco-Guerra, Camilo Jose</creatorcontrib><creatorcontrib>Martinez-Ávila, Maria Cristina</creatorcontrib><creatorcontrib>Almanza Hurtado, Amilkar J</creatorcontrib><creatorcontrib>Rodriguez Yanez, Tómas</creatorcontrib><creatorcontrib>Gutierrez-Ariza, Juan Camilo</creatorcontrib><creatorcontrib>Rico-Fontalvo, Jorge</creatorcontrib><title>When to Use Antibiotics in COVID-19: A Proposal Based on Questions</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>The COVID-19 pandemic has affected millions of people, including hundreds of deaths. The search for adequate treatments and interventions that influence poor prognostic factors and reduce mortality has led to excessive use of antibiotics based on the possible existence of bacterial co-infection. However, there is no evidence to justify the systematic use of antimicrobials in COVID-19. The recommendations seek to provide knowledge regarding treatment; standardizing a management algorithm requires validation in clinical trials and studies of greater methodological rigor.</description><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Bacterial infections</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Cytokines</subject><subject>Drug resistance</subject><subject>Infectious Disease</subject><subject>Mortality</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Pneumonia</subject><subject>Public Health</subject><subject>Pulmonology</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Staphylococcus infections</subject><subject>Viral infections</subject><subject>Viruses</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkc1LAzEQxYMoVmpvniXgxYNbk2w22XgQ2voJhSpYPYZsNquRbVKTXcH_3q2tos5lBubH4z0eAAcYDTnPxKlug2njkPBU5Ftgj2CWJznO6favuwcGMb4ihDDiBHG0C3opQ5QRwffA-OnFONh4OI8GjlxjC-sbqyO0Dk5mj7cXCRZncATvgl_6qGo4VtGU0Dt435rYWO_iPtipVB3NYLP7YH51-TC5Saaz69vJaJrolJIm4RUhZSZwoXFa6kqjLCuI0lmFmSC8oIUReWloVRnNC14yQg0hDOOCkW4YS_vgfK27bIuFKbVxTVC1XAa7UOFDemXl34-zL_LZv0tBcc4I6gSONwLBv63cy4WN2tS1csa3URKOBMI5wrRDj_6hr74Nrou3onLGhKArwZM1pYOPMZjqxwxGctWPXPcjv_rp8MPfAX7g7zbST9thirU</recordid><startdate>20220728</startdate><enddate>20220728</enddate><creator>Dueñas-Castell, Carmelo</creator><creator>Polanco-Guerra, Camilo Jose</creator><creator>Martinez-Ávila, Maria Cristina</creator><creator>Almanza Hurtado, Amilkar J</creator><creator>Rodriguez Yanez, Tómas</creator><creator>Gutierrez-Ariza, Juan Camilo</creator><creator>Rico-Fontalvo, Jorge</creator><general>Cureus Inc</general><general>Cureus</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220728</creationdate><title>When to Use Antibiotics in COVID-19: A Proposal Based on Questions</title><author>Dueñas-Castell, Carmelo ; Polanco-Guerra, Camilo Jose ; Martinez-Ávila, Maria Cristina ; Almanza Hurtado, Amilkar J ; Rodriguez Yanez, Tómas ; Gutierrez-Ariza, Juan Camilo ; Rico-Fontalvo, Jorge</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c342t-7f22d591bc13dcfc055b2ac5f16927b4be98de4ffec7b7d624e22611b62222663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Bacterial infections</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Cytokines</topic><topic>Drug resistance</topic><topic>Infectious Disease</topic><topic>Mortality</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Pneumonia</topic><topic>Public Health</topic><topic>Pulmonology</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Staphylococcus infections</topic><topic>Viral infections</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dueñas-Castell, Carmelo</creatorcontrib><creatorcontrib>Polanco-Guerra, Camilo Jose</creatorcontrib><creatorcontrib>Martinez-Ávila, Maria Cristina</creatorcontrib><creatorcontrib>Almanza Hurtado, Amilkar J</creatorcontrib><creatorcontrib>Rodriguez Yanez, Tómas</creatorcontrib><creatorcontrib>Gutierrez-Ariza, Juan Camilo</creatorcontrib><creatorcontrib>Rico-Fontalvo, Jorge</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dueñas-Castell, Carmelo</au><au>Polanco-Guerra, Camilo Jose</au><au>Martinez-Ávila, Maria Cristina</au><au>Almanza Hurtado, Amilkar J</au><au>Rodriguez Yanez, Tómas</au><au>Gutierrez-Ariza, Juan Camilo</au><au>Rico-Fontalvo, Jorge</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>When to Use Antibiotics in COVID-19: A Proposal Based on Questions</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2022-07-28</date><risdate>2022</risdate><volume>14</volume><issue>7</issue><spage>e27398</spage><pages>e27398-</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>The COVID-19 pandemic has affected millions of people, including hundreds of deaths. The search for adequate treatments and interventions that influence poor prognostic factors and reduce mortality has led to excessive use of antibiotics based on the possible existence of bacterial co-infection. However, there is no evidence to justify the systematic use of antimicrobials in COVID-19. The recommendations seek to provide knowledge regarding treatment; standardizing a management algorithm requires validation in clinical trials and studies of greater methodological rigor.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>36046297</pmid><doi>10.7759/cureus.27398</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2168-8184 |
| ispartof | Curēus (Palo Alto, CA), 2022-07, Vol.14 (7), p.e27398 |
| issn | 2168-8184 2168-8184 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9418620 |
| source | PubMed Central Open Access; PubMed Central |
| subjects | Antibiotics Antimicrobial agents Bacterial infections Coronaviruses COVID-19 Cytokines Drug resistance Infectious Disease Mortality Pandemics Patients Pneumonia Public Health Pulmonology Severe acute respiratory syndrome coronavirus 2 Staphylococcus infections Viral infections Viruses |
| title | When to Use Antibiotics in COVID-19: A Proposal Based on Questions |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T21%3A42%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=When%20to%20Use%20Antibiotics%20in%20COVID-19:%20A%20Proposal%20Based%20on%20Questions&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Due%C3%B1as-Castell,%20Carmelo&rft.date=2022-07-28&rft.volume=14&rft.issue=7&rft.spage=e27398&rft.pages=e27398-&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.27398&rft_dat=%3Cproquest_pubme%3E2709018014%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2708669940&rft_id=info:pmid/36046297&rfr_iscdi=true |